DaBomb Protein Biotech Corp. (6578.TWO)

TWD 19.2

(-2.54%)

EBITDA Summary of DaBomb Protein Biotech Corp.

  • DaBomb Protein Biotech Corp.'s latest annual EBITDA in 2023 was -25.99 Million TWD , down -67.82% from previous year.
  • DaBomb Protein Biotech Corp.'s latest quarterly EBITDA in 2024 Q3 was 10.57 Million TWD , down -11.57% from previous quarter.
  • DaBomb Protein Biotech Corp. reported an annual EBITDA of -15.49 Million TWD in 2022, up 62.04% from previous year.
  • DaBomb Protein Biotech Corp. reported an annual EBITDA of -40.8 Million TWD in 2021, down -202.45% from previous year.
  • DaBomb Protein Biotech Corp. reported a quarterly EBITDA of 10.57 Million TWD for 2024 Q3, down -11.57% from previous quarter.
  • DaBomb Protein Biotech Corp. reported a quarterly EBITDA of 11.95 Million TWD for 2024 Q2, down -12.32% from previous quarter.

Annual EBITDA Chart of DaBomb Protein Biotech Corp. (2023 - 2019)

Historical Annual EBITDA of DaBomb Protein Biotech Corp. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 -25.99 Million TWD -67.82%
2022 -15.49 Million TWD 62.04%
2021 -40.8 Million TWD -202.45%
2020 39.82 Million TWD -20.2%
2019 49.91 Million TWD 0.0%

Peer EBITDA Comparison of DaBomb Protein Biotech Corp.

Name EBITDA EBITDA Difference
Tehmag Foods Corporation 1.1 Billion TWD 102.351%
SunWay Biotech Co., LTD. 83.46 Million TWD 131.146%
Hantech Bio-Technology Co., Ltd. 198.26 Million TWD 113.112%
Lian Fa International Dining Business Corp. 187.19 Million TWD 113.888%
Jia Jie Biomedical Co., Ltd. 161.78 Million TWD 116.069%
Microbio Co., Ltd. -261.3 Million TWD 90.051%
Chung Hwa Food Industrial Co., Ltd. 461.41 Million TWD 105.634%
Far East Bio-Tec Co., Ltd. 49.07 Million TWD 152.971%
We Can Medicines Co., Ltd. 321.24 Million TWD 108.093%
Wonder Pets Enterprises Corporation 404.28 Million TWD 106.43%
Eagle Cold Storage Enterprise Co., Ltd. 374.67 Million TWD 106.939%